After 70 years, a new class of drugs for schizophrenia
A new type of drug for schizophrenia could finally be approved in September. Others may not be far behind.
neurotransmission
A novel candidate drug improves multiple sclerosis signs in mice
An allosteric inhibitor may block glutamate’s toxic effects in the brain without affecting healthy synaptic neurotransmission.
